BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 7773151)

  • 21. Acute monoblastic/monocytic leukemia and chronic myelomonocytic leukemia share common immunophenotypic features but differ in the extent of aberrantly expressed antigens and amount of granulocytic cells.
    Kern W; Bacher U; Haferlach C; Schnittger S; Haferlach T
    Leuk Lymphoma; 2011 Jan; 52(1):92-100. PubMed ID: 21219126
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Terminal deoxynucleotidyl transferase and CD7 expression in acute myeloid leukemias are not associated with a high frequency of immunoglobulin and/or T cell receptor gene rearrangement.
    Willière G; Stockinger H; Köller U; Majdic O; Schnabl E; Lutz D; Bettelheim P; Knapp W
    Leukemia; 1990 Apr; 4(4):278-81. PubMed ID: 1694941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The value of immunohistochemistry for CD14, CD123, CD33, myeloperoxidase and CD68R in the diagnosis of acute and chronic myelomonocytic leukaemias.
    Rollins-Raval MA; Roth CG
    Histopathology; 2012 May; 60(6):933-42. PubMed ID: 22348485
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of trisomy 8 on cytobiological and clinical features of acute myelomonocytic and monocytic leukemia.
    Tian L; Liu LB; Wang XB; Xiao J; Zou P
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Jun; 13(3):364-8. PubMed ID: 15972121
    [TBL] [Abstract][Full Text] [Related]  

  • 25. P-glycoprotein and multidrug resistance associated protein-1 activity in 132 acute myeloid leukemias according to FAB subtypes and cytogenetics risk groups.
    Legrand O; Zompi S; Perrot JY; Faussat AM; Benderra Z; Chaoui D; Marie JP
    Haematologica; 2004 Jan; 89(1):34-41. PubMed ID: 14754604
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CBF beta-SMMHC, expressed in M4Eo AML, reduced CBF DNA-binding and inhibited the G1 to S cell cycle transition at the restriction point in myeloid and lymphoid cells.
    Cao W; Britos-Bray M; Claxton DF; Kelley CA; Speck NA; Liu PP; Friedman AD
    Oncogene; 1997 Sep; 15(11):1315-27. PubMed ID: 9315100
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Absence of retinoblastoma protein expression results in autocrine production of interleukin-6 and promotes the autonomous growth of acute myeloid leukemia blast cells.
    Zhu YM; Bradbury DA; Keith FJ; Russell N
    Leukemia; 1994 Nov; 8(11):1982-8. PubMed ID: 7967742
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Acute monocytic or myelomonocytic leukemia with balanced chromosome translocations to band 11q23 after therapy with 4-epi-doxorubicin and cisplatin or cyclophosphamide for breast cancer.
    Pedersen-Bjergaard J; Sigsgaard TC; Nielsen D; Gjedde SB; Philip P; Hansen M; Larsen SO; Rørth M; Mouridsen H; Dombernowsky P
    J Clin Oncol; 1992 Sep; 10(9):1444-51. PubMed ID: 1517787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Frequent aberration of FHIT gene expression in acute leukemias.
    Iwai T; Yokota S; Nakao M; Nakazawa N; Taniwaki M; Kimura T; Sonoda Y; Kaneko H; Okuda T; Azuma H; Oka T; Takeda T; Watanabe A; Kikuta A; Asami K; Sekine I; Matsushita T; Tsuchiya T; Mimaya J; Koizumi S; Ohta S; Miyake M; Takaue Y; Iwai A; Fujimoto T
    Cancer Res; 1998 Nov; 58(22):5182-7. PubMed ID: 9823330
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Expression of MUC1 gene and MDR1 gene in non-M3 subtype acute leukemia and their correlations to clinical treatment efficacy].
    Li GW; Wang DN; Lin DJ; Li XD; Lin GZ; He Y; Lin Q; Huang RW
    Ai Zheng; 2005 Aug; 24(8):1011-4. PubMed ID: 16086884
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heterogeneous expression of the product of the retinoblastoma susceptibility gene in primary human leukemia cells.
    Furukawa Y; DeCaprio JA; Belvin M; Griffin JD
    Oncogene; 1991 Aug; 6(8):1343-6. PubMed ID: 1886710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tetrasomy 8 in a patient with acute monoblastic leukemia.
    Kim J; Park TS; Song J; Lee KA; Lee SG; Cheong JW; Choi JR
    Korean J Lab Med; 2008 Aug; 28(4):262-6. PubMed ID: 18728374
    [TBL] [Abstract][Full Text] [Related]  

  • 33. M4 and M5 acute myeloid leukaemias display a high sensitivity to Bortezomib-mediated apoptosis.
    Riccioni R; Senese M; Diverio D; Riti V; Buffolino S; Mariani G; Boe A; Cedrone M; Lo-Coco F; Foà R; Peschle C; Testa U
    Br J Haematol; 2007 Oct; 139(2):194-205. PubMed ID: 17897295
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Alkaline phosphatase is a useful cytochemical marker for the diagnosis of acute myelomonocytic and monocytic leukemia in the dog.
    Stokol T; Schaefer DM; Shuman M; Belcher N; Dong L
    Vet Clin Pathol; 2015 Mar; 44(1):79-93. PubMed ID: 25546124
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Retinoid X Receptor alpha is increased upon monocytic cell differentiation.
    Defacque H; Commes T; Legouffe E; Sevilla C; Rossi JF; Rochette-Egly C; Marti J
    Biochem Biophys Res Commun; 1996 Mar; 220(2):315-22. PubMed ID: 8645303
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Butyrates, as a single drug, induce histone acetylation and granulocytic maturation: possible selectivity on core binding factor-acute myeloid leukemia blasts.
    Gozzini A; Rovida E; Dello Sbarba P; Galimberti S; Santini V
    Cancer Res; 2003 Dec; 63(24):8955-61. PubMed ID: 14695213
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytoprotective effects of hematopoietic growth factors on primary human acute myeloid leukemias are not mediated through changes in BCL-2, bax, or p21WAF1/CIP1.
    DiGiuseppe JA; Kastan MB; Weng LJ; Gore SD
    In Vivo; 1999; 13(1):1-6. PubMed ID: 10218124
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Generation of a MLL-AF9-specific stem cell model of acute monocytic leukemia.
    Chiew MY; Boo NY; Voon K; Cheong SK; Leong PP
    Leuk Lymphoma; 2017 Jan; 58(1):162-170. PubMed ID: 27185517
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of transforming growth factor beta, tumor necrosis factor alpha, interferon gamma and LIF-HILDA on the proliferation of acute myeloid leukemia cells.
    Kerangueven F; Sempere C; Tabilio A; Mannoni P
    Eur Cytokine Netw; 1990; 1(2):99-107. PubMed ID: 2129395
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The RET receptor tyrosine kinase, but not its specific ligand, GDNF, is preferentially expressed by acute leukaemias of monocytic phenotype and is up-regulated upon differentiation.
    Gattei V; Degan M; Rossi FM; De Iuliis A; Mazzocco FT; Cesa E; Aldinucci D; Zagonel V; Pinto A
    Br J Haematol; 1999 Apr; 105(1):225-40. PubMed ID: 10233387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.